Table 1.
Before PS matching (overall group) | After PS matching* | |||||
---|---|---|---|---|---|---|
COVID-19 (N = 18,278) |
Non-COVID-19 (N = 5,501,604) |
aSD | COVID-19 (N = 17,401) |
Non-COVID-19 (N = 17,401) |
aSD | |
Age, years | 50.0 | 51.2 | 0.068 | 48.8 | 48.6 | 0.016 |
Charlson Comorbidity Index | 1.923 | 1.523 | 0.194 | 1.650 | 1.768 | 0.055 |
Sex (%) | ||||||
Male | 47.4% | 49.5% | 0.043 | 47.6% | 47.5% | 0.003 |
Female | 52.6% | 50.5% | 0.043 | 52.4% | 52.5% | 0.003 |
Index date (%) | ||||||
February 2020–May 2020 | 18.0% | 47.8% | 0.298 | 18.9% | 20.1% | 0.012 |
June 2020–September 2020 | 17.3% | 49.6% | 0.323 | 18.0% | 17.8% | 0.020 |
October 2020–February 2021 | 66.8% | 5.3% | 0.615 | 65.3% | 64.3% | 0.010 |
Values are numbers (percentages) unless stated otherwise. PS, propensity score; aSD, absolute standardized difference.
*Balance in covariate distribution between two groups was assessed using the absolute standardized mean difference.